while also evaluating the performance of the new inhaler without a spacer. Breztri generated $677m in global sales in 2023, ...
A high-tech device that can monitor medication use and compliance has been cleared by the FDA for use with AstraZeneca’s Airsupra and Breztri inhalers. Developed by Australian medtech firm ...